Advertisement
CNO vs MET
Which Stock Would AI Choose? CNO Financial Group (CNO) vs. MetLife (MET) Stock Comparison
Key Takeaways
- CNO delivered strong Q1 2026 results with operating earnings per share up 33% to $1.05, marking its 15th consecutive quarter of sales growth.
- MET recently increased its quarterly dividend by 4.4%, underscoring robust cash generation amid upcoming Q1 earnings.
- CNO YTD performance stands at +5.52%, outperforming MET's +2.36% in recent market activity.
- Both stocks trade at comparable forward P/E ratios (price-to-earnings) around 17, but MET provides a higher dividend yield of 2.95% versus CNO's 1.52%.
- CNO's smaller market cap of $4.2B contrasts with MET's $51.8B, offering potential for nimbler growth but elevated risk exposure.
- Recent momentum positions CNO near its 52-week high, reflecting positive sentiment shifts.
Introduction
This CNO vs. MET stock comparison examines two prominent players in the insurance sector. CNO Financial Group targets middle-income seniors in the U.S. with Medicare supplements, annuities, and life products, while MetLife offers a global portfolio spanning group benefits, retirement solutions, and asset management. Investors and traders evaluating relative performance in insurance may find value here, particularly amid shifting interest rates and demographic trends influencing sector dynamics. This analysis highlights recent price behavior, sentiment, and key metrics for informed market positioning.
CNO Overview and Recent Performance
CNO Financial Group specializes in insurance products for middle-income pre-retirees and retirees, including Medicare supplement policies, supplemental health, annuities, and life insurance under brands like Bankers Life and Colonial Penn. In recent market activity, the stock has traded around $44.63, near its 52-week high of $44.94, with a market cap of $4.2 billion. Q1 2026 results showed operating earnings per share rising 33% to $1.05, driven by robust sales across segments and favorable insurance dynamics, extending sales growth to 15 quarters. Sentiment has improved on these beats and AM Best's rating affirmation, supporting YTD gains of 5.52% despite a beta of 0.83 indicating moderate volatility.
MET Overview and Recent Performance
MetLife operates globally in insurance, annuities, employee benefits, and asset management across segments like Group Benefits, Asia, and Europe. The stock recently hovered at $80.23, within a 52-week range of $67.33-$83.85, backed by a substantial $51.8 billion market cap. Anticipation builds for Q1 2026 earnings, with analysts eyeing EPS of $2.23, following a 4.4% dividend hike to 2.95% yield that bolsters shareholder appeal. YTD performance at 2.36% reflects steady positioning amid broader sector pressures, aided by a low beta of 0.77 and diversified revenue streams, though recent share movements show resilience without sharp surges.
Trending AI Robots
Tickeron's Trending AI Robots page curates 25 top-performing AI trading bots from over 350 available, each designed to trade thousands of tickers including stocks, ETFs, and crypto across diverse strategies like trend following, swing trading, and volatility plays. These bots showcase impressive stats: annualized returns from +23% to +163%, win rates of 51%-88%, profit factors up to 11.70, and profit-to-drawdown ratios reaching 17.02, with timeframes from 1 day to 49 days. Focused on high-momentum sectors like semiconductors, data centers, and leveraged ETFs, they employ AI/ML for signal generation, risk management, and TP/SL corridors. Traders can explore these curated options suited to current volatile conditions for potential outperformance versus benchmarks like the S&P 500.
Head-to-Head Comparison
CNO and MET both anchor the life and health insurance space but diverge in scale and focus. CNO's niche U.S. senior market drives nimble growth via Medicare and annuity sales, contrasting MET's broader global exposure to group benefits and emerging markets for stability. Recent momentum favors CNO with earnings beats and YTD outperformance, while MET counters with superior dividend appeal and lower beta for risk-averse positioning. CNO faces higher sector concentration risks, whereas MET navigates currency and geopolitical factors. Comparable P/E ratios highlight valuation parity, with trade-offs in growth potential versus income reliability.
Tickeron AI Verdict
Tickeron's AI would currently lean toward CNO based on trend consistency from sustained sales growth, Q1 earnings strength, and superior relative YTD performance positioning it near highs. While MET offers stability and yield advantages, CNO's catalysts suggest higher near-term probability of outperformance in the insurance sector.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNO is a StrongBuy and MET is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNO’s FA Score shows that 2 FA rating(s) are green whileMET’s FA Score has 3 green FA rating(s).
- CNO’s FA Score: 2 green, 3 red.
- MET’s FA Score: 3 green, 2 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNO’s TA Score shows that 4 TA indicator(s) are bullish while MET’s TA Score has 5 bullish TA indicator(s).
- CNO’s TA Score: 4 bullish, 4 bearish.
- MET’s TA Score: 5 bullish, 4 bearish.
Price Growth
CNO (@Life/Health Insurance) experienced а +5.50% price change this week, while MET (@Life/Health Insurance) price change was +5.15% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +3.45%. For the same industry, the average monthly price growth was +1.38%, and the average quarterly price growth was +3.35%.
Reported Earning Dates
CNO is expected to report earnings on Aug 03, 2026.
MET is expected to report earnings on Aug 05, 2026.
Industries' Descriptions
@Life/Health Insurance (+3.45% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
| CNO | MET | CNO / MET | |
| Capitalization | 4.7B | 57.2B | 8% |
| EBITDA | N/A | N/A | - |
| Gain YTD | 19.511 | 14.215 | 137% |
| P/E Ratio | 20.31 | 17.18 | 118% |
| Revenue | 4.51B | 76B | 6% |
| Total Cash | N/A | 121B | - |
| Total Debt | 4.3B | 21.1B | 20% |
CNO | MET | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 34 | 35 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 58 Fair valued | 33 Fair valued | |
PROFIT vs RISK RATING 1..100 | 14 | 37 | |
SMR RATING 1..100 | 89 | 96 | |
PRICE GROWTH RATING 1..100 | 42 | 17 | |
P/E GROWTH RATING 1..100 | 18 | 27 | |
SEASONALITY SCORE 1..100 | 50 | 37 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MET's Valuation (33) in the Life Or Health Insurance industry is in the same range as CNO (58). This means that MET’s stock grew similarly to CNO’s over the last 12 months.
CNO's Profit vs Risk Rating (14) in the Life Or Health Insurance industry is in the same range as MET (37). This means that CNO’s stock grew similarly to MET’s over the last 12 months.
CNO's SMR Rating (89) in the Life Or Health Insurance industry is in the same range as MET (96). This means that CNO’s stock grew similarly to MET’s over the last 12 months.
MET's Price Growth Rating (17) in the Life Or Health Insurance industry is in the same range as CNO (42). This means that MET’s stock grew similarly to CNO’s over the last 12 months.
CNO's P/E Growth Rating (18) in the Life Or Health Insurance industry is in the same range as MET (27). This means that CNO’s stock grew similarly to MET’s over the last 12 months.
| CNO | MET | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 61% | 3 days ago 60% |
| Stochastic ODDS (%) | 3 days ago 60% | 3 days ago 54% |
| Momentum ODDS (%) | 3 days ago 60% | 3 days ago 56% |
| MACD ODDS (%) | 3 days ago 70% | 3 days ago 58% |
| TrendWeek ODDS (%) | 3 days ago 60% | 3 days ago 58% |
| TrendMonth ODDS (%) | 3 days ago 60% | 3 days ago 50% |
| Advances ODDS (%) | 3 days ago 62% | 3 days ago 63% |
| Declines ODDS (%) | 17 days ago 50% | 18 days ago 55% |
| BollingerBands ODDS (%) | 3 days ago 72% | 3 days ago 50% |
| Aroon ODDS (%) | 3 days ago 56% | 3 days ago 47% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| NVIR | 39.13 | 0.29 | +0.74% |
| Horizon Kinetics Energy Remediation ETF | |||
| NML | 10.18 | 0.04 | +0.39% |
| Neuberger Energy Infrastructure and Income Fund Inc. | |||
| SEPZ | 45.08 | 0.18 | +0.39% |
| TrueShares Structured Outcome Sep ETF | |||
| FBTC | 55.35 | 0.06 | +0.11% |
| Fidelity Wise Origin Bitcoin Fund | |||
| ZTOP | 51.66 | N/A | N/A |
| F/m High Yield 100 ETF | |||
CNO and
Correlation & Price change
A.I.dvisor indicates that over the last year, CNO has been closely correlated with JXN. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if CNO jumps, then JXN could also see price increases.